Suzanne Goodrich

Suzanne Goodrich

Auto-generated profile, based on publicly available information

Suzanne Goodrich

Division of Infectious Diseases, Department of Medicine, Indiana University School of Medicine , Indianapolis, Indiana

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 April 2024 in Journal of the International AIDS Society
Verified
Journal Article
Open access
MPMarie Kerbie Plaisy
Marie Kerbie Plaisy
AMAlbert K. Minga
Albert K. Minga
GWGilles Wandeler
Gilles Wandeler
GMGad Murenzi
Gad Murenzi
NSNiharika Samala
Niharika Samala
TAthe Sentinel Research Network of the International epidemiology Databases to Evaluate AIDS
the Sentinel Research Network of the International epidemiology Databases to Evaluate AIDS
Introduction: Liver disease is a leading cause of morbidity and mortality among persons living with HIV (PLHIV). While chronic viral hepatitis has been extensively studied in low‐ and middle‐income countries (LMICs), there is limited information about the burden of metabolic disorders on liver disease in PLHIV.Methods: We conducted a cross‐sectional analysis of baseline data collected between October 2020 and July 2022 from the IeDEA‐Sentinel Research Network, a prospective cohort enrolling PLHIV ≥40 years on antiretroviral treatment (ART) for ≥6 months from eight clinics in Asia, Americas, and central, East, southern and West Africa. Clinical assessments, laboratory testing on fasting blood samples and liver stiffness measurement (LSM)/controlled attenuation parameter (CAP) by vibration‐controlled transient elastography were performed. Multivariable logistic regression models assessed factors associated with liver fibrosis (LSM ≥7.1 kPa) and steatosis (CAP ≥248 dB/m). Population attributable fraction (PAF) of each variable associated with significant liver fibrosis was estimated using Levin's formula.Results: Overall, 2120 PLHIV (56% female, median age 50 [interquartile range: 45−56] years) were included. The prevalence of obesity was 19%, 12% had type 2 diabetes mellitus (T2DM), 29% had hypertension and 53% had dyslipidaemia. The overall prevalence of liver fibrosis and steatosis was 7.6% (95% confidence interval [CI] 6.1−8.4) and 28.4% (95% CI 26.5−30.7), respectively, with regional variability. Male sex at birth (odds ratio [OR] 1.62, CI 1.10−2.40), overweight/obesity (OR = 2.50, 95% CI 1.69−3.75), T2DM (OR 2.26, 95% CI 1.46−3.47) and prolonged exposure to didanosine (OR 3.13, 95% CI 1.46−6.49) were associated with liver fibrosis. Overweight/obesity and T2DM accounted for 42% and 11% of the PAF for liver fibrosis, while HBsAg and anti‐HCV accounted for 3% and 1%, respectively. Factors associated with steatosis included overweight/obesity (OR 4.25, 95% CI 3.29−5.51), T2DM (OR 2.06, 95% CI 1.47−2.88), prolonged exposure to stavudine (OR 1.69, 95% CI 1.27−2.26) and dyslipidaemia (OR 1.68, 95% CI 1.31−2.16).Conclusions: Metabolic disorders were significant risk factors for liver disease among PLHIV in LMICs. Early recognition of metabolic disorders risk factors might be helpful to guide clinical and lifestyle interventions. Further prospective studies are needed to determine the causative natures of these findings.

19 March 2024 in PLOS Global Public Health
Verified
Journal Article
Open access
PDF file
EKEdith Kamaru Kwobah
Edith Kamaru Kwobah
SGSuzanne Goodrich
Suzanne Goodrich
JKJayne Lewis Kulzer
Jayne Lewis Kulzer
MKMichael Kanyesigye
Michael Kanyesigye
SOSarah Obatsa
Sarah Obatsa
KWKara Wools-Kaloustian
Kara Wools-Kaloustian
Research increasingly involves cross-cultural work with non-English-speaking populations, necessitating translation and cultural validation of research tools. This paper describes the process of translating and criterion validation of the Client Diagnostic Questionnaire (CDQ) for use in a multisite study in Kenya and Uganda. The English CDQ was translated into Swahili, Dholuo (Kenya) and Runyankole/Rukiga (Uganda) by expert translators. The translated documents underwent face validation by a bilingual committee, who resolved unclear statements, agreed on final translations and reviewed back translations to English. A diagnostic interview by a mental health specialist was used for criterion validation, and Kappa statistics assessed the strength of agreement between non-specialist scores and mental health professionals’ diagnoses. Achieving semantic equivalence between translations was a challenge. Validation analysis was done with 30 participants at each site (median age 32.3 years (IQR = (26.5, 36.3)); 58 (64.4%) female). The sensitivity was 86.7%, specificity 64.4%, positive predictive value 70.9% and negative predictive value 82.9%. Diagnostic accuracy by the non-specialist was 75.6%. Agreement was substantial for major depressive episode and positive alcohol (past 6 months) and alcohol abuse (past 30 days). Agreement was moderate for other depressive disorders, panic disorder and psychosis screen; fair for generalized anxiety, drug abuse (past 6 months) and Post Traumatic Stress Disorder (PTSD); and poor for drug abuse (past 30 days). Variability of agreement between sites was seen for drug use (past 6 months) and PTSD. Our study successfully adapted the CDQ for use among people living with HIV in East Africa. We established that trained non-specialists can use the CDQ to screen for common mental health and substance use disorders with reasonable accuracy. Its use has the potential to increase case identification, improve linkage to mental healthcare, and improve outcomes. We recommend further studies to establish the psychometric properties of the translated tool.

28 February 2023 in PLOS Global Public Health
Verified
Journal Article
Open access
PDF file
AMAdel Mburia-Mwalili
Adel Mburia-Mwalili
KWKarla D Wagner
Karla D Wagner
EKEdith Kamaru Kwobah
Edith Kamaru Kwobah
LALukoye Atwoli
Lukoye Atwoli
MAMaurice Aluda
Maurice Aluda
JSJennifer L Syvertsen
Jennifer L Syvertsen
As coronavirus disease (COVID-19) was declared a pandemic in 2020, countries around the world implemented various prevention strategies, such as banning of public and social gatherings, restriction in movement, etc. These efforts may have had a deleterious effect on already vulnerable populations, including people living with HIV (PLWH). PLWH were concerned about contracting COVID-19, the impact of COVID-19 on their social networks that provide social support, and the continued availability of antiretroviral medications during the pandemic. In addition, their mental health may have been exacerbated by the pandemic. The purpose of this study was to explore pandemic-related concerns among a cohort of PLWH in Kenya and investigate social support factors associated with symptoms of depression and anxiety. This study is part of a larger cohort study that recruited from two clinics in Western Kenya. Data are drawn from 130 PLWH who participated in two phone surveys about experiences during the pandemic in 2020 and 2021. Participants reported a variety of concerns over the course of the pandemic and we documented statistically significant increases in symptoms of depression and anxiety over time, which affected some participants’ ability to adhere to their antiretroviral medication. However, a small but statistically significant group of participants reached out to expand their networks and mobilize support in the context of experiencing mental health and adherence challenges, speaking to the importance of social support as a coping strategy during times of stress. Our findings call for holistic approaches to HIV care that consider the broader political, economic, and social contexts that shape its effectiveness.

29 March 2023 in PLOS Global Public Health
Verified
Journal Article
Open access
PDF file
JHJohn M Humphrey
John M Humphrey
MAMarsha Alera
Marsha Alera
LELeslie A Enane
Leslie A Enane
BKBett Kipchumba
Bett Kipchumba
SGSuzanne Goodrich
Suzanne Goodrich
KWKara Wools-Kaloustian
Kara Wools-Kaloustian
Although an estimated 1.4 million women living with HIV (WHIV) are pregnant each year globally, data describing the effects of the COVID-19 pandemic on postpartum women in low- and middle-income countries (LMICs) are limited. To address this gap, we conducted phone surveys among 170 WHIV ≥18 years and 18–24 months postpartum enrolled in HIV care at the Academic Model Providing Access to Healthcare in western Kenya, and assessed the effects of the pandemic across health, social and economic domains. We found that 47% of WHIV experienced income loss and 71% experienced food insecurity during the pandemic. The majority (96%) of women reported having adequate access to antiretroviral treatment and only 3% reported difficulties refilling medications, suggesting that the program’s strategies to maintain HIV service delivery during the early phase of the pandemic were effective. However, 21% of WHIV screened positive for depression and 8% for anxiety disorder, indicating the need for interventions to address the mental health needs of this population. Given the scale and duration of the pandemic, HIV programs in LMICs should work with governments and non-governmental organizations to provide targeted support to WHIV at highest risk of food and income insecurity and their associated adverse health outcomes.

1 July 2026 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
KPKirsten Prabhudas-Strycker
Kirsten Prabhudas-Strycker
LDLameck Diero
Lameck Diero
WMWinnie Muyindike
Winnie Muyindike
HBHelen Byakwaga
Helen Byakwaga
SKSylvia Kitur
Sylvia Kitur
Leslie EnaneLeslie Enane
Leslie Enane
Background: Although timely tuberculosis (TB) diagnosis and treatment are essential to TB elimination, care delays remain a challenge. Understanding factors associated with delayed TB diagnosis and treatment may inform interventions. Methods: The TB Sentinel Research Network of the International epidemiology Databases to Evaluate AIDS (IeDEA) is a prospective study of people aged ≥15 years with pulmonary TB. At sites in Eldoret, Kenya, and Mbarara, Uganda, questionnaires ascertained timing of recalled TB symptom onset, number/setting of healthcare visits prior to TB diagnosis, symptoms, demographics, food insecurity, and TB- and HIV-related stigma. Robust negative binomial regression was used to examine factors associated with longer overall duration from TB symptom onset to documented treatment initiation. Results: Among 264 participants—median age 33 years (IQR, 25–43 years), 67% male, 31% people with HIV, 51% urban residents—median duration from TB symptom onset to treatment initiation was 65.5 days (IQR, 33–131 days). Longer time to TB treatment was associated with female sex (adjusted incidence rate ratio [aIRR], 1.27 [95% CI, 1.00–1.61]); previous care-seeking at a pharmacy (aIRR, 1.53 [95% CI, 1.22–1.92]), and presence of dyspnea (aIRR, 1.43 [95% CI, 1.09–1.86]) or fatigue (aIRR, 1.63 [95% CI, 1.11–2.37]) at initiation. Shorter duration to TB treatment was associated with HIV-positive status (aIRR, 0.50 [95% CI, .39–.64]). Among people with HIV, shorter duration to TB treatment was associated with CD4 count <200 cells/μL (aIRR, 0.63 [95% CI, .43–.93]). Conclusions: Interventions are needed to increase community-level TB diagnostic access, including at pharmacies and lower levels of care. Decentralized TB testing strategies and tailored interventions for groups with lower care access should be pursued.

24 June 2026 in PLOS Global Public Health
Verified
Journal Article
Open access
SOSarah Obatsa
Sarah Obatsa
AMAdel Mburia-Mwalili
Adel Mburia-Mwalili
SJSalvador Jauregui
Salvador Jauregui
KWKarla Wagner
Karla Wagner
LALukoye Atwoli
Lukoye Atwoli
JSJennifer L. Syvertsen
Jennifer L. Syvertsen
The disclosure of one’s HIV-positive status is a personal decision that can play an important role in engagement in HIV treatment and care. Social network approaches situate individuals within broader webs of social connections that influence health and wellbeing and thus hold the potential to elucidate key social factors shaping the process of disclosure. As part of a larger clinical study examining how substance use and mental health shape HIV outcomes, we recruited 61 individuals newly diagnosed with HIV at two clinics in Western Kenya to participate in an egocentric social networks study. We conducted a survey that generated a visual network map to guide a subsequent qualitative interview about experiences being diagnosed and living with HIV. We thematically analyzed the qualitative data and visual network maps to examine the social contexts and patterns of HIV disclosure, with the goal of identifying supportive contexts of disclosure. The mean age was 36.7 years (range: 20–62); women were significantly younger than men and more likely to self-report a mental health issue. Typically, participants disclosed their HIV-positive status to a small number of close, trusted alters in their network, including intimate partners, siblings and other family members, and friends. The need for mental health support in the wake of a new diagnosis, especially among women, encouraged disclosure. Across nearly all stories, stigma was a powerful deterrent to sharing one’s status, and multiple people noted prior disclosure to others not named in their current networks because their relationships were negatively impacted. Our study shows how the intersection of social relationships, mental health, and stigma is critical in understanding decision-making processes around disclosure. Selective disclosure typically improved participants’ wellbeing while stigma precluded disclosure and exacerbated distress. Our study offers suggestions for social network interventions to support people living with HIV/AIDS.